Treatment News : New Ideas About Reaching HIV Sanctuaries in the Body

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Treatment News » June 2009

Most Popular Links
Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

20 Years Ago In POZ

More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to


June 22, 2009

New Ideas About Reaching HIV Sanctuaries in the Body

A joint U.S. and Canadian team of researchers say they have confirmed how specific immune cells serve as a protected reservoir of HIV, despite potent antiretroviral (ARV) therapy. They also offer ideas for eradicating that sanctuary of cells—and the virus along with it—in a study published online June 21 in Nature Medicine.

Scientists once though that HIV might be eradicated in people who kept their viral loads undetectable for several years using ARV therapy. Ultimately, they learned that HIV manages to hide out in some very long-lived cells in lymph nodes throughout the body that remain unaffected by HIV treatment. When ARV therapy is stopped, the virus comes roaring back.

Nicolas Chomont, PhD, from the Université de Montréal, Canada, and his colleagues in Montreal and Florida claim they have now confirmed which cells specifically serve as hidden sanctuaries, and how those cells manage to replicate new virus even when potent ARV therapy is being used.

The cells in question are memory CD4s—cells programmed, often in childhood, at the time of an initial infection with a disease-causing microorganism. This particular group of cells was determined to be the long-lived sanctuary of HIV more than 10 years ago.

Chomont’s team went one step further and believes it has confirmed why memory CD4s aren’t vulnerable to HIV drugs—the cells subdivide, thus replicating not only the cells, but also the virus that has become embedded in the cells’ genetic code. ARV treatment can’t reach that virus because HIV remains in the cells that are actively replicating.

The authors hope that they and other scientists may be able to develop a one-two punch that will include not only ARV therapy, but also drugs that keep the memory CD4 cells from dividing. According to Chomont, if ARV therapy is used long enough, and most of the infected cells die, then there is a chance that the infection may ultimately burn itself out.

Search: hiv, sanctuaries, memory CD4 cells, T-lymphocytes, recalcitrant, antiretroviral, ARV, Chomont

Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Show comments (2 total)

[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Did you participate in an event for National Black HIV/AIDS Awareness Day 2016?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.